Skip to content
DataLookout
Menu

NCT06856226

Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant

StatusRecruiting
PhaseNot specified
Primary completion (estimated)

At risk: Primary completion moved 3 years later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

The 50 most recent of 231 versions: 47 with changes below, 3 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion pushed from Dec 1, 2027 to Dec 1, 2030
    • Study completion pushed from Dec 1, 2028 to Dec 1, 2031
  2. Minor Start date changed from estimate of Mar 11, 2026 to Mar 4, 2026v227
  3. Minor Start date: Mar 10, 2026 to Mar 11, 2026v226
  4. Minor Start date: Mar 9, 2026 to Mar 10, 2026v225
  5. Minor Start date: Mar 8, 2026 to Mar 9, 2026v224
Show 42 earlier versionsHide 42 earlier versions
  1. Minor Start date: Mar 5, 2026 to Mar 8, 2026v223
  2. Minor Start date: Mar 4, 2026 to Mar 5, 2026v222
  3. Minor Start date: Mar 3, 2026 to Mar 4, 2026v221
  4. Minor Start date: Mar 2, 2026 to Mar 3, 2026v220
  5. Minor Start date: Mar 1, 2026 to Mar 2, 2026v219
  6. Minor Start date: Feb 26, 2026 to Mar 1, 2026v218
  7. Minor Start date: Feb 25, 2026 to Feb 26, 2026v217
  8. Minor Start date: Feb 24, 2026 to Feb 25, 2026v216
  9. Minor Start date: Feb 23, 2026 to Feb 24, 2026v215
  10. Minor Start date: Feb 22, 2026 to Feb 23, 2026v214
  11. Minor Start date: Feb 9, 2026 to Feb 22, 2026v213
  12. Minor Start date: Feb 3, 2026 to Feb 9, 2026v212
  13. Minor Start date: Feb 2, 2026 to Feb 3, 2026v211
  14. Minor Start date: Feb 1, 2026 to Feb 2, 2026v210
  15. Minor Start date: Jan 29, 2026 to Feb 1, 2026v209
  16. Minor Start date: Jan 28, 2026 to Jan 29, 2026v208
  17. Minor Start date: Jan 27, 2026 to Jan 28, 2026v207
  18. Minor Start date: Jan 26, 2026 to Jan 27, 2026v206
  19. Minor Start date: Jan 22, 2026 to Jan 26, 2026v205
  20. Minor Start date: Jan 21, 2026 to Jan 22, 2026v204
  21. Minor Start date: Jan 20, 2026 to Jan 21, 2026v203
  22. Minor Start date: Jan 19, 2026 to Jan 20, 2026v202
  23. Minor Start date: Jan 18, 2026 to Jan 19, 2026v201
  24. Minor Start date: Jan 15, 2026 to Jan 18, 2026v200
  25. Minor Start date: Jan 14, 2026 to Jan 15, 2026v199
  26. Minor Start date: Jan 13, 2026 to Jan 14, 2026v198
  27. Minor Start date: Jan 12, 2026 to Jan 13, 2026v197
  28. Minor Start date: Jan 11, 2026 to Jan 12, 2026v196
  29. Minor Start date: Jan 8, 2026 to Jan 11, 2026v195
  30. Minor Start date: Jan 6, 2026 to Jan 8, 2026v194
  31. Minor Start date: Jan 5, 2026 to Jan 6, 2026v193
  32. Minor Start date: Jan 4, 2026 to Jan 5, 2026v192
  33. Minor Start date: Jan 1, 2026 to Jan 4, 2026v191
  34. Minor Start date: Dec 30, 2025 to Jan 1, 2026v190
  35. Minor Start date: Dec 29, 2025 to Dec 30, 2025v189
  36. Minor Start date: Dec 28, 2025 to Dec 29, 2025v188
  37. Minor Start date: Dec 25, 2025 to Dec 28, 2025v187
  38. Minor Start date: Dec 24, 2025 to Dec 25, 2025v186
  39. Minor Start date: Dec 23, 2025 to Dec 24, 2025v185
  40. Minor Start date: Dec 22, 2025 to Dec 23, 2025v184
  41. Minor Start date: Dec 21, 2025 to Dec 22, 2025v183
  42. Minor Start date: Dec 18, 2025 to Dec 21, 2025v182
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

To determine the most reliable host genomic source for pharmacogenetic testing in participants that have received allogeneic hematopoietic stem cell transplant (HSCT)
Timeframe: Pharmacoscan array will be performed within 1 month pre-BM donation in donors and within 1 month pre-HSCT and 12 months post-HSCT in recipients.

Arms and interventions

Cohort 1

Participants undergoing allogeneic HSCT and donors

Other: Arm 1

Sites

1 site in 1 country

  • National Institutes of Health Clinical CenterBethesda, Maryland, United States